Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
388.80M | 368.90M | 309.00M | 90.60M | 311.60M | Gross Profit |
134.00M | 172.80M | 140.90M | -14.60M | 147.10M | EBIT |
28.60M | 43.40M | 51.70M | -35.10M | 37.90M | EBITDA |
63.70M | 76.90M | 82.60M | -2.90M | 70.80M | Net Income Common Stockholders |
11.10M | 29.70M | 34.40M | -38.30M | 19.30M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
16.90M | 10.70M | 34.00M | 4.70M | 1.10M | Total Assets |
1.35B | 1.05B | 1.06B | 997.50M | 989.60M | Total Debt |
376.50M | 175.90M | 207.80M | 253.40M | 281.50M | Net Debt |
359.60M | 165.20M | 173.80M | 248.70M | 280.40M | Total Liabilities |
578.00M | 329.70M | 362.20M | 352.10M | 398.80M | Stockholders Equity |
771.60M | 724.20M | 699.70M | 645.40M | 590.80M |
Cash Flow | Free Cash Flow | |||
17.40M | 42.70M | 65.00M | -42.10M | 26.10M | Operating Cash Flow |
65.90M | 82.90M | 101.90M | -23.00M | 59.00M | Investing Cash Flow |
-199.60M | -52.30M | -14.10M | -18.70M | -67.20M | Financing Cash Flow |
132.40M | -53.90M | -58.50M | 45.30M | 800.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | £47.06B | 42.68 | 20.56% | 1.72% | 6.81% | -14.09% | |
70 Outperform | £267.35M | ― | -2.83% | ― | 3.02% | 29.25% | |
68 Neutral | £1.30B | 8.78 | 5.81% | ― | 4.27% | ― | |
64 Neutral | £693.95M | 14.65 | 12.15% | 2.02% | 5.74% | -16.78% | |
61 Neutral | £455.15M | 27.33 | 1.44% | 3.81% | 16.73% | -55.22% | |
61 Neutral | £297.06M | 15.56 | 2.11% | 3.43% | 2.22% | 98.79% | |
60 Neutral | $13.01B | 10.45 | 0.79% | 3.53% | 1.60% | -22.47% |